IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 8293 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1428    
    Printed137    
    Emailed0    
    PDF Downloaded95    
    Comments [Add]    

Recommend this journal

 

 SHORT COMMUNICATION
Year : 1992  |  Volume : 24  |  Issue : 3  |  Page : 174-175

Verapamil - A potential ocular hypotensive agent



Correspondence Address:
S K Gupta


Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

The ocular hypotensive effect of a single topical application of verapamil was studied in albino rabbits. In normotensive rabbits, after base line measurement of intraocular pressure (IOP) with applanation tonometer, 30 'l drops of verapamil in the concentration of 0.125% was instilled in one eye while contra-lateral eye received the vehicle and served as control. The IOP measurements were taken at 30 min., 2, 4 and 8 hrs. The onset of pressure lowering effect was observed at 30 minutes, with a peak effect at two hours and persisted up to 8 hrs. The hypotensive effect of verapamil was also studied after water loading in twelve rabbits. The reduction of pressure was more marked (6r1.20 vs 4ñ 0.14 mm Hg) in water loaded rabbit's eyes as compared to normotensive eyes which was statistically significant (P < .001) when compared with base line values and with the contralaterarcontrol eyes.






[PDF]*


        
Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow